United States· US:43598-169_d20e2c0a-b04d-5e4a-a28b-442e0a77f3b6
Enalaprilat
A medicinal product containing enalaprilat, registered in United States by Dr. Reddys Laboratories Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ENALAPRILAT
- Manufacturer
- Dr. Reddys Laboratories Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11435981695810 VIAL in 1 CARTON (43598-169-58) / 2 mL in 1 VIAL (43598-169-11)
- ndc1143598-169-58
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Enalaprilat in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaENALAPRILAT INJECTION USPHIKMA CANADA LIMITED
- GermanyEnahexal I.V.Hexal Ag
- FinlandRenitecMerck Sharp & Dohme B.V.
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Bulgaria · Енап
- Czechia · Enap
- Germany · Enahexal I.V.
- Estonia · Enap
- Hungary · Enap
- Lithuania · Enap
- Latvia · Enap
- Romania · Enap
- Slovenia · Enap
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4973d9d1-be59-4794-8b8f-049822153fca GET /v1/drugs/4973d9d1-be59-4794-8b8f-049822153fca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "2.5",
"substance": "ENALAPRILAT",
"productndc": "43598-169",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/2mL",
"application_number": "ANDA075578",
"marketing_category": "ANDA"
}See everything about enalaprilat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.